Clinical Trials Browser

Terminated × Has results × tipifarnib × Clear all

NCT03496766 2025-03-05

Tipifarnib in Advanced Squamous NSCLC With Oncogen HRAS MutAtionS

Phase 2 Terminated

9 enrolled 22 charts

Carcinoma, Non-Small-Cell Lung